NISSAY ASSET MANAGEMENT CORP /JAPAN

Position in UTHR — UNITED THERAPEUTICS Corp

CIK 869589 Tokyo, M0

Back to UTHR Full portfolio

Position in UTHR

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$2,934,551

-$231,962 QoQ

Shares Held

5,416

+1.4% QoQ

Ownership

0.013%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#317

of 870 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in UTHR Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

NISSAY ASSET MANAGEMENT CORP /JAPAN holds $14,333,135 across 4 Drug Manufacturers - Specialty & Generic names. UTHR ranks #3 (20.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TEVA	Teva Pharmaceutical Industries Ltd	152,835	$5,178,049
2	ZTS	Zoetis Inc.	57,334	$4,120,021
3	UTHR	UNITED THERAPEUTICS Corp This page	5,416	$2,934,551
4	NBIX	Neurocrine Biosciences Inc	12,463	$2,100,514

All Filings in UTHR

Export CSV

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,934,551	5,416	+1.4%	Shares	Sole	2026-08-14
2026-03-31	$3,166,513	5,340	-2.8%	Shares	Sole	2026-05-15
2025-12-31	$2,677,438	5,495	+0.3%	Shares	Sole	2026-02-17
2025-09-30	$2,297,270	5,480	+0.7%	Shares	Sole	2025-11-14
2025-06-30	$1,564,046	5,443	+4.0%	Shares	Sole	2025-08-14
2025-03-31	$1,613,793	5,235	+0.8%	Shares	Sole	2025-05-15
2024-12-31	$1,831,945	5,192	+1.2%	Shares	Sole	2025-02-14
2024-09-30	$1,838,693	5,131	-2.8%	Shares	Sole	2024-11-14
2024-06-30	$1,681,944	5,280	-2.3%	Shares	Sole	2024-08-14
2024-03-31	$1,240,947	5,402	+1.7%	Shares	Sole	2024-05-15
2023-12-31	$1,168,055	5,312	+4.3%	Shares	Sole	2024-02-14
2023-09-30	$1,150,581	5,094	+4.5%	Shares	Sole	2023-11-14
2023-06-30	$1,076,156	4,875	+4.6%	Shares	Sole	2023-08-14
2023-03-31	$1,044,101	4,662	—	Shares	Sole	2023-05-15
No filing history on record for this holder in this stock.